698 related articles for article (PubMed ID: 30427405)
1. Hand, foot and mouth disease and herpangina caused by enterovirus A71 infections: a review of enterovirus A71 molecular epidemiology, pathogenesis, and current vaccine development.
Chang YK; Chen KH; Chen KT
Rev Inst Med Trop Sao Paulo; 2018 Nov; 60():e70. PubMed ID: 30427405
[TBL] [Abstract][Full Text] [Related]
2. The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China.
Jiang H; Zhang Z; Rao Q; Wang X; Wang M; Du T; Tang J; Long S; Zhang J; Luo J; Pan Y; Chen J; Ma J; Liu X; Fan M; Zhang T; Sun Q
Emerg Microbes Infect; 2021 Dec; 10(1):619-628. PubMed ID: 33682641
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Nonpolio Enteroviruses in Children With Herpangina and Hand, Foot and Mouth Disease in Taiwan.
Yang TO; Arthur Huang KY; Chen MH; Chen PC; Huang WT
Pediatr Infect Dis J; 2019 Sep; 38(9):887-893. PubMed ID: 31033911
[TBL] [Abstract][Full Text] [Related]
4. Enterovirus A71: virulence, antigenicity, and genetic evolution over the years.
Huang SW; Cheng D; Wang JR
J Biomed Sci; 2019 Oct; 26(1):81. PubMed ID: 31630680
[TBL] [Abstract][Full Text] [Related]
5. Clinically isolated enterovirus A71 subgenogroup C4 strain with lethal pathogenicity in 14-day-old mice and the application as an EV-A71 mouse infection model.
Xu Y; Ma S; Zhu L; Huang Z; Chen L; Xu Y; Yin H; Peng T; Wang Y
Antiviral Res; 2017 Jan; 137():67-75. PubMed ID: 27864074
[TBL] [Abstract][Full Text] [Related]
6. EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases.
Mao Q; Wang Y; Bian L; Xu M; Liang Z
Emerg Microbes Infect; 2016 Jul; 5(7):e75. PubMed ID: 27436364
[TBL] [Abstract][Full Text] [Related]
7. Enterovirus A71 Containing Codon-Deoptimized VP1 and High-Fidelity Polymerase as Next-Generation Vaccine Candidate.
Tsai YH; Huang SW; Hsieh WS; Cheng CK; Chang CF; Wang YF; Wang JR
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996087
[TBL] [Abstract][Full Text] [Related]
8. Molecular epidemiology and clinical features of hand, foot and mouth disease requiring hospitalization after the use of enterovirus A71 inactivated vaccine in chengdu, China, 2017-2022: a descriptive study.
Duan X; Zhang C; Wang X; Ren X; Peng H; Tang X; Zhang L; Chen Z; Ye Y; Zheng M; Zhong W; Chen X; Zeng Y; Yuan P; Long L
Emerg Microbes Infect; 2022 Dec; 11(1):2510-2519. PubMed ID: 36103331
[TBL] [Abstract][Full Text] [Related]
9. [Analysis on epidemiological characteristics of enterovirus 71 cases of hand-foot-mouth disease based on the active monitoring in Guangdong Province in 2011-2015].
Xie DS; He JF; Yang F; Li H; Kang M; Zhang M; Ye X; Tan XH; Ni XH; Hu L; Sun LM
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jul; 52(7):738-742. PubMed ID: 29996302
[No Abstract] [Full Text] [Related]
10. Is a multivalent hand, foot, and mouth disease vaccine feasible?
Klein M; Chong P
Hum Vaccin Immunother; 2015; 11(11):2688-704. PubMed ID: 26009802
[TBL] [Abstract][Full Text] [Related]
11. Establishment of Asia-Pacific Network for Enterovirus Surveillance.
Chiu ML; Luo ST; Chen YY; Chung WY; Duong V; Dussart P; Chan YF; Perera D; Ooi MH; Thao NTT; Truong HK; Lee MS
Vaccine; 2020 Jan; 38(1):1-9. PubMed ID: 31679864
[TBL] [Abstract][Full Text] [Related]
12. Outbreak of hand, foot and mouth disease/herpangina associated with coxsackievirus A6 and A10 infections in 2010, France: a large citywide, prospective observational study.
Mirand A; Henquell C; Archimbaud C; Ughetto S; Antona D; Bailly JL; Peigue-Lafeuille H
Clin Microbiol Infect; 2012 May; 18(5):E110-8. PubMed ID: 22404077
[TBL] [Abstract][Full Text] [Related]
13. The History of Enterovirus A71 Outbreaks and Molecular Epidemiology in the Asia-Pacific Region.
Puenpa J; Wanlapakorn N; Vongpunsawad S; Poovorawan Y
J Biomed Sci; 2019 Oct; 26(1):75. PubMed ID: 31627753
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological and etiological characteristics of herpangina and hand foot mouth diseases in Jiangsu, China, 2013-2014.
Yao X; Bian LL; Lu WW; Li JX; Mao QY; Wang YP; Gao F; Wu X; Ye Q; Li XL; Zhu FC; Liang Z
Hum Vaccin Immunother; 2017 Apr; 13(4):823-830. PubMed ID: 27768527
[TBL] [Abstract][Full Text] [Related]
15. Epidemiologic features of hand-foot-mouth disease and herpangina caused by enterovirus 71 in Taiwan, 1998-2005.
Chen KT; Chang HL; Wang ST; Cheng YT; Yang JY
Pediatrics; 2007 Aug; 120(2):e244-52. PubMed ID: 17671037
[TBL] [Abstract][Full Text] [Related]
16. EV71: an emerging infectious disease vaccine target in the Far East?
Xu J; Qian Y; Wang S; Serrano JM; Li W; Huang Z; Lu S
Vaccine; 2010 Apr; 28(20):3516-21. PubMed ID: 20304038
[TBL] [Abstract][Full Text] [Related]
17. Diseases caused by enterovirus 71 infection.
Lee TC; Guo HR; Su HJ; Yang YC; Chang HL; Chen KT
Pediatr Infect Dis J; 2009 Oct; 28(10):904-10. PubMed ID: 20118685
[TBL] [Abstract][Full Text] [Related]
18. Genetic evolution of Human Enterovirus A71 subgenotype C4 in Shenzhen, China, 1998-2013.
He Y; Zou L; Chong MKC; Men R; Xu W; Yang H; Yao X; Chen L; Xian H; Zhang H; Luo M; Cheng J; Ma H; Feng Q; Huang Y; Wang Y; Yeoh EK; Zee BC; Zhou Y; He ML; Wang MH
J Infect; 2016 Jun; 72(6):731-737. PubMed ID: 27038503
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of EV-A71 vaccination in prevention of paediatric hand, foot, and mouth disease associated with EV-A71 virus infection requiring hospitalisation in Henan, China, 2017-18: a test-negative case-control study.
Li Y; Zhou Y; Cheng Y; Wu P; Zhou C; Cui P; Song C; Liang L; Wang F; Qiu Q; Guo C; Zeng M; Long L; Cowling BJ; Yu H
Lancet Child Adolesc Health; 2019 Oct; 3(10):697-704. PubMed ID: 31375313
[TBL] [Abstract][Full Text] [Related]
20. PREVALENCE OF HUMAN ENTEROVIRUS AMONG PATIENTS WITH HAND, FOOT, AND MOUTH DISEASE AND HERPANGINA IN THAILAND, 2013.
Mauleekoonphairoj J; Puenpa J; Korkong S; Vongpunsawad S; Poovorawan Y
Southeast Asian J Trop Med Public Health; 2015 Nov; 46(6):1013-20. PubMed ID: 26867359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
